Abstract

Within the publishing industry, article numbering has emerged as an easy and efficient way to cite journal articles. Article numbering has already been successfully rolled out to Elseviers multidisciplinary open access journal Heliyon, as well as more than 200 other journals, and has been well received by the academic community. Based on that positive feedback, we are now pleased to introduce article numbering to Immuno-Oncology and Technology. A unique article number is an abbreviated form of an articles DOI - digital object identifier. Citing an article with an article number is very simple: the article number is used instead of the page range in the citation. 2. Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. Heliyon. 2018;19:100205. https://doi.org/10.1016/j.heliyon.2018.100205. While journal volumes and issue numbers will remain in place, article numbering will now play the key role in identifying specific articles. The introduction of article numbers brings several benefits for the journal and its readers and authors. ‱More flexible reading: Article content can be optimized based on the device used to access it, supporting reading on-the-move, without needing to know how many traditional print pages the article takes up.‱Increased options for grouping related content: In online collections and Special Issues, articles can now be placed in any order, helping readers to identify papers relevant to their research interests faster.‱Faster publication: With article numbers, the version of record of the article is online and citable as soon as the proof corrections have been incorporated, ensuring readers have access to the latest research faster. We are delighted that Immuno-Oncology and Technologys readers and authors will now enjoy these benefits.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.